Dr. Peter Rosenbaum, MD, FRCP(C), joined the faculty of McMaster University in July 1973 and has been a Professor of Pediatrics since 1984. He held one of the inaugural Tier 1 Canada Research Chairs (2001-2014), and was the Director of the McMaster Child Health Research Institute (2007-2012). In 2009, he served as the Acting Chair of the Department of Pediatrics.
With Dr. Mary Law, Dr. Rosenbaum was the co-founder in 1989 of the award-winning CanChild Centre for Childhood Disability Research, a health system-linked research unit funded 1989-2009 by the Ontario Ministry of Health and Long-Term Care. CanChild is now recognized world-wide for its research and dissemination activities in the field of childhood disability.
Dr. Rosenbaum has held more than 80 peer-reviewed research grants and is a contributing author to over 300 peer-reviewed journal articles and book chapters. He has been an invited lecturer and keynote speaker in 25 countries. He co-authored ‘Cerebral Palsy: From Diagnosis to Adult Life’ (2012), and co-edited ‘Life Quality Outcomes of Children and Young Adults with Neurological and Developmental Conditions’ (2013) with Dr. Gabriel Ronen. In 2015 he and colleagues are working on a book on ethical dilemmas in developmental medicine.
Dr. Rosenbaum has been a graduate supervisor or committee member with over 50 master’s and doctoral level students, at the Universities of Oxford, Utrecht, Witwatersrand, and Toronto in addition to McMaster. Since 2012 he has been a consultant to UNICEF’s Expert Consultation on the Collection of Data on Children with Disabilities.
Dr. Rosenbaum’s accomplishments have been recognized nationally and internationally. He was the first Canadian President of AACPDM (1996-8); received the Ross Award from the Canadian Pediatric Society (2000); holds an Honorary Doctor of Science, Université Laval (2005); received the Academy’s Mentorship Award (2007) and its Lifetime Achievement Award (2014); and in June 2015, Dr Rosenbaum received the inaugural Holland Bloorview Medal of Excellence for “outstanding achievement and leadership in making positive global advancements in the field of childhood disability. The award is our Board of Trustees’ highest honour.”
